Enteral administration of a synthetic monoacetyldiglyceride improves survival in a murine model of abdominal sepsis

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 1, 2010, Pages 62-68

  Hong, John J ^a   Koh, Younsuck ^b   Park, Jung Sun ^b   Jung, Hyun Don ^b   Kim, Sang Hee B ^b   Lee, Tae Suk ^c   Badellino, Michael M ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c R and D Center   (South Korea)

Author keywords

Bone marrow stem cells; Cecal ligation and puncture (CLP); Monoacetyldiglyceride (MADG); Sepsis; Stem cell factor (SCF); Stromal cell derived factor (SDF 1)

Indexed keywords

DIACYLGLYCEROL DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MONOACETYLDIGLYCERIDE 3; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMOKINE; CXCL12 PROTEIN, MOUSE; CYTOKINE; DIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL LIGATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; STROMA CELL; SURVIVAL RATE; ANIMAL; C3H MOUSE; LIVER; LUNG; METABOLISM; MORTALITY; ORAL DRUG ADMINISTRATION; SYNTHESIS;

ADMINISTRATION, ORAL; ANIMALS; CHEMOKINE CXCL12; CHEMOKINES; CYTOKINES; DIGLYCERIDES; LIVER; LUNG; MALE; MICE; MICE, INBRED C3H; SEPSIS; STEM CELL FACTOR; SURVIVAL RATE;

EID: 75649083122     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181c3fede     Document Type: Article

References (30)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
3. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
4. Marshall J. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov. 2003;2:391-405.
5. Kleiman R, Miller RW, Earle FR, Wolff IA. Optically active acetotriglycerides of oil from Euonymus verrucosus seed. Lipids. 1966;1: 286-287.
6. Myher JJ, Kuksis A, Marai L, Sandra P. Identification of the more complex triacylglycerols in bovine milk fat by gas chromatographymass spectrometry using polar capillary columns. J Chromatogr. 1988; 452:93-118.
7. Limb JK, Kim YH, Han SY, Jhon GJ. Isolation and characterization of monoacetyldiglycerides from bovine udder. J Lipid Res. 1999;40: 2169-2176.
8. Yang HO, Kim SH, Cho SH, et al. Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler). Chem Pharm Bull. 2004;52:874-878.
9. Yang HO, Park JS, Cho SH, et al. Stimulatory effects of monoacetyldiglycerides on hematopoiesis. Biol Pharm Bull. 2004;27:1121-1125.
10. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res. 1980;29:189-201.
11. Ao X, Sellati TJ, Stenken JA. Enhanced microdialysis relative recovery of inflammatory cytokines using antibody-coated microspheres analyzed by flow cytometry. Anal Chem. 2004;76:3777-3784.
12. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005;4:854-865.
13. Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med. 2002;166:1197-1205.
14. Eaves CJ. SDF-1 tells stem cells to mind their P's and Z's. J Clin Invest. 2005;115:27-29.
15. Dalakas E, Newsome PN, Harrison DJ, Plevris JN. Hematopoietic stem cell trafficking in liver injury. FASEB J. 2005;19:1225-1231.
16. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005;105:3793-3801.
17. Link DC. Neutrophil homeostasis: a new role for stromal cell-derived factor-1. Immunol Res. 2005;32:169-178.
18. Nanki T, Lipsky PE. Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4-T cell activation. J Immunol. 2000;164:5010-5014.
19. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol. 1993;142:965-974.
20. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol. 1994;153:3717-3723.
21. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol. 1994;144:321-328.
22. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90: 1345-1364.
23. Maurer M, Echtenacher B, Hultner L, et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med. 1998;188:2343-2348.
24. Bone-Larson CL, Hogaboam CM, Steinhauser ML, et al. Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. Am J Pathol. 2000;157:1177-1186.
25. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75-77.
26. Valent P, Spanblochl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992;80:2237-2245.
27. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381:77-80.
28. Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol. 2006;533: 327-340.
29. Suzuki Y, Rahman M, Mitsuya H. Diverse transcriptional response of CD4(-) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(-) T cells. J Immunol. 2001;167:3064-3073.
30. Kishore SP, Bungum MK, Platt JL, Brunn GJ. Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4. FEBS Lett. 2005;579:699-704.